| 000 | 01769 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513160043.0 | ||
| 264 | 0 | _c19990111 | |
| 008 | 199901s 0 0 eng d | ||
| 022 | _a0036-8075 | ||
| 024 | 7 |
_a10.1126/science.282.5397.2272 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCarlezon, W A | |
| 245 | 0 | 0 |
_aRegulation of cocaine reward by CREB. _h[electronic resource] |
| 260 |
_bScience (New York, N.Y.) _cDec 1998 |
||
| 300 |
_a2272-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCocaine _xadministration & dosage |
| 650 | 0 | 4 | _aConditioning, Psychological |
| 650 | 0 | 4 |
_aCyclic AMP Response Element-Binding Protein _xgenetics |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDynorphins _xgenetics |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 | _aGene Transfer Techniques |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 |
_aNaltrexone _xanalogs & derivatives |
| 650 | 0 | 4 |
_aNarcotic Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aNeurons _xmetabolism |
| 650 | 0 | 4 |
_aNucleus Accumbens _xmetabolism |
| 650 | 0 | 4 | _aPoint Mutation |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Opioid, kappa _xantagonists & inhibitors |
| 650 | 0 | 4 | _aReward |
| 650 | 0 | 4 |
_aSimplexvirus _xgenetics |
| 700 | 1 | _aThome, J | |
| 700 | 1 | _aOlson, V G | |
| 700 | 1 | _aLane-Ladd, S B | |
| 700 | 1 | _aBrodkin, E S | |
| 700 | 1 | _aHiroi, N | |
| 700 | 1 | _aDuman, R S | |
| 700 | 1 | _aNeve, R L | |
| 700 | 1 | _aNestler, E J | |
| 773 | 0 |
_tScience (New York, N.Y.) _gvol. 282 _gno. 5397 _gp. 2272-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1126/science.282.5397.2272 _zAvailable from publisher's website |
| 999 |
_c9820036 _d9820036 |
||